Table 4.
Serum b-FGF and VEGF levels in patients with active GO before and after corticosteroid treatment (mean ± SD)
| Before corticosteroid treatment | After corticosteroid treatment | ||
|---|---|---|---|
| b-FGF (pg/ml) | Corticosteroid-responsive (n = 25) | 124.61 ± 38.30a c e | 78.00 ± 14.19d |
| Corticosteroid-resistant (n = 9) | 100.23 ± 41.62b e | 91.07 ± 38.54 | |
| Inactive GO (n = 14) | 78.58 ± 17.37 | ||
| VEGF (pg/ml) | Corticosteroid-responsive (n = 25) | 250.58 ± 71.69a c e | 133.46 ± 34.97d |
| Corticosteroid-resistant (n = 9) | 192.58 ± 53.24b e | 163.57 ± 44.79 | |
| Inactive GO (n = 14) | 132.34 ± 42.19 | ||
| CAS | Corticosteroid-responsive (n = 25) | 7.50 ± 2.61a c e | 2.54 ± 1.12d |
| Corticosteroid-resistant (n = 9) | 4.08 ± 1.98b e | 3.21 ± 1.56 | |
| Inactive GO (n = 14) | 2.57 ± 0.65 | ||
| OI | Corticosteroid-responsive (n = 25) | 9.75 ± 1.83a c e | 4.63 ± 1.02 |
| Corticosteroid-resistant (n = 9) | 7.82 ± 1.13b e | 4.51 ± 1.18 | |
| Inactive GO (n = 14) | 5.71 ± 1.54 |
–vs. post-treatment values, a P < 0.05, b P > 0.05;
–vs. corticosteroid-resistance, c P < 0.05, d P > 0.05;
–vs. Inactive GO, e P < 0.05, f P > 0.05;